14/09/2026
The final RareCare reports are now live. 📣
RareCare is an NIHR-funded evaluation of the UK Rare Diseases Framework and England’s Rare Diseases Action Plans.
We were proud to be involved in and contribute to this important work.
The programme brings together lived experience, healthcare professional insight, indicator development and routine health data analysis to explore what progress in rare disease policy looks like and how it could be measured in future.
The reports highlight important progress in rare disease policy, research and infrastructure. They also show that policy ambition does not automatically translate into improved experiences for people living with rare diseases and their families.
A key message from RareCare is that future rare disease policy needs to consider:
• system-level change
• service-level delivery
• lived experience and family impact
This matters because completing actions is not the same as knowing whether diagnosis, care, support and access are improving in people’s lives.
RareCare is an important evidence base for the next phase of rare disease policy.
All the reports can be read here 👉 https://rarecare.online
To find out what happens next join RareCare, the Office for Life Sciences, Genetic Alliance UK, and Breaking Down Barriers on 17 September, 13:00–14:00 BST, for RareCare: What Happens Next? Turning Evidence into Action.